You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 13, 2025

Details for Patent: 11,622,959


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,622,959 protect, and when does it expire?

Patent 11,622,959 protects SOHONOS and is included in one NDA.

This patent has twenty-four patent family members in sixteen countries.

Summary for Patent: 11,622,959
Title:Methods for treating heterotopic ossification
Abstract:The invention features dosing regimens and pharmaceutical formulations for oral administration of palovarotene. The dosing regimens can reduce heterotopic ossification, reduce the number of flare-ups, and/or reduce the severity of flare-ups in subjects suffering from fibrodysplasia ossificans progressiva.
Inventor(s):Clarissa Desjardins, Donna Roy GROGAN, Jeffrey Neal PACKMAN, Mark Harnett
Assignee:Clementia Pharmaceuticals Inc
Application Number:US16/950,604
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of a U.S. Patent: A Detailed Analysis

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the specifics of patent claims, the patent landscape, and provide a detailed analysis using the example of U.S. Patent 11,622,959.

What is a Patent?

A patent is a property right granted by the U.S. government to an inventor, allowing them to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States for a specified period, typically 20 years from the filing date of the patent application[2].

Types of Patents

There are several types of patents, but the most common is the utility patent, which covers new and useful processes, machines, manufactures, or compositions of matter, or any new and useful improvement thereof[2].

The Patent Application Process

The patent application process involves several steps, including filing a provisional or non-provisional application, conducting a prior art search, and undergoing examination by a patent examiner. The application must include essential documents such as a specification, drawings, an oath or declaration, and claims that define the scope of the patent's protection[2].

Patent Claims

Patent claims are the heart of a patent application, as they define what is protected by the patent. There are two main types of claims: independent claims and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit an independent claim[2].

Metrics for Measuring Patent Scope

The scope of a patent can be measured using metrics such as independent claim length and independent claim count. Narrower claims, as indicated by shorter independent claim lengths and fewer independent claims, are often associated with a higher probability of grant and a shorter examination process[3].

Patent Prosecution

During patent prosecution, a patent examiner reviews the application to ensure the claimed invention is useful, novel, and non-obvious. If the examiner finds issues, an Office Action is issued, and the applicant must respond. This process can involve multiple rounds of examination, appeals, or requests for continued examination[2].

Continuation Procedures

Continuation procedures are crucial in the patent prosecution process. These include non-serialized continuations like Requests for Continued Examination (RCEs) and serialized continuations such as Continuations, Continuations-in-Part (CIPs), and Divisional applications. These procedures allow applicants to pursue additional claims or address examiner rejections while maintaining the priority date of the original application[1].

Patent Allowance Rates

Understanding the probability of receiving a patent involves analyzing various allowance rates. The first-action allowance rate, progenitor allowance rate, and family allowance rate provide insights into the likelihood of an application being granted. For instance, the family allowance rate indicates the proportion of progenitor applications that produce at least one patent, including outcomes from continuation applications[1].

Example: U.S. Patent 11,622,959

To illustrate the concepts discussed, let's consider U.S. Patent 11,622,959, though specific details of this patent are not provided here. Here’s a general approach to analyzing such a patent:

Reading the Patent

  • Start by reading the abstract, which provides a brief summary of the invention.
  • Review the background of the invention to understand the context and prior art.
  • Examine the detailed description of the invention, including any drawings or diagrams.
  • Analyze the claims, focusing on both independent and dependent claims to understand the scope of protection.

Claim Analysis

  • Identify the independent claims, which define the broadest scope of the invention.
  • Look at dependent claims to see how they further limit the independent claims.
  • Use metrics like independent claim length and count to gauge the patent's scope and potential for enforcement.

Prosecution History

  • Review the prosecution history to see how the claims were amended or argued during the examination process.
  • Check for any Office Actions, responses, and appeals to understand the examiner's concerns and the applicant's arguments.

Continuation Procedures

  • Determine if any continuation procedures were used, such as RCEs or serialized continuations, and how they affected the patent's scope and priority date.

Key Takeaways

  • Patent Claims: The claims are the most critical part of a patent application, defining what is protected.
  • Patent Scope: Metrics like independent claim length and count can help measure the scope and potential enforceability of a patent.
  • Prosecution Process: Understanding the prosecution history, including Office Actions and responses, is essential for analyzing the strength and validity of a patent.
  • Continuation Procedures: These procedures can significantly impact the patent's scope, priority date, and overall strategy.

FAQs

Q: What is the primary purpose of patent claims in a patent application? A: The primary purpose of patent claims is to define the scope of protection for the invention, specifying what is protected by the patent.

Q: How do continuation procedures affect the patent application process? A: Continuation procedures allow applicants to pursue additional claims, address examiner rejections, and maintain the priority date of the original application, potentially leading to multiple patents from a single progenitor application.

Q: What metrics can be used to measure the scope of a patent? A: Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent, with narrower claims often associated with a higher probability of grant and shorter examination process.

Q: What is the difference between a provisional and a non-provisional patent application? A: A provisional patent application allows for an early filing date with fewer formal requirements, while a non-provisional application must comply with all statutory requirements and is necessary for obtaining a utility patent.

Q: How long does a patent typically last in the United States? A: A patent typically lasts for 20 years from the filing date of the non-provisional patent application.

Sources

  1. Carley, M., & Hegde, D. "What Is the Probability of Receiving a US Patent?" Yale Journal on Regulation, 2013.
  2. The Maryland People's Law Library. "Patents," 2024.
  3. SSRN. "Patent Claims and Patent Scope," 2016.
  4. National Science Foundation. "Invention, Knowledge Transfer, and Innovation," 2024.
  5. USA.gov. "U.S. Patent and Trademark Office (USPTO)," 2024.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 11,622,959

Showing 1 to 5 of 5 entries

International Family Members for US Patent 11,622,959

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 2017276835 ⤷  Try for Free
Australia 2022202148 ⤷  Try for Free
Brazil 112018075422 ⤷  Try for Free
Canada 3025854 ⤷  Try for Free
Chile 2018003502 ⤷  Try for Free
China 109562099 ⤷  Try for Free
Eurasian Patent Organization 201892497 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.